Real-life experience of a stent-less revascularization strategy using a combination of excimer laser and drug-coated balloon for patients with acute coronary syndrome.

OBJECTIVES: We aimed to test a novel stent-less revascularization strategy using a combination of excimer laser coronary angioplasty (ELCA) and drug-coated balloon (DCB) for patients with acute coronary syndrome (ACS). BACKGROUND: Percutaneous coronary intervention with drug eluting stents is a standard invasive treatment for ACS. Some unsolved issues however remain, such as stent thrombosis and bleeding risks associated with dual antiplatelet therapy. METHODS: Consecutive ACS patients were planned to receive either a DCB application following ELCA without a stent implantation or conventional revascularization with a coronary stent. The endpoints were (i) major cardiac adverse events (MACEs), defined as the composite of cardiac death, myocardial infarctions, and target lesion revascularization; (ii) target vessel revascularization (TVR); and (iii) angiographic outcome. RESULTS: Since a greater than expected number of patients allocated to the stent-less treatment arm eventually received a bailout stenting, the following 3 as-treated groups were compared; DCB with ELCA group (N = 60), Stent with ELCA group (N = 23), and Stent without ELCA group (N = 85). During a mean follow-up period of 420 ± 137 days, and with angiographic 6- and 12-month-follow-up rates of 96.7%, 87%, and 81.2%, and 50%, 65.2%, and 45.9%, respectively, the MACE rate did not differ across the groups (10%, 4.3%, and 3.5%; P = 0.22) while an incidence of TVR was more common (15%, 0, and 4.7%; P = 0.02) and the diameter stenosis at 6-months of follow-up was greater (25.7 ± 18.2, 14.9 ± 13.1 and 16.2 ± 15.4%; P = 0.002) in the DCB with ELCA group. CONCLUSIONS: The stent-less revascularization strategy with DCB and ELCA was associated with a higher occurrence of restenosis in ACS patients.

Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

BACKGROUND: Distal embolization during percutaneous coronary intervention (PCI) may deteriorate microvascular reperfusion in patients with ST-elevation myocardial infarction (STEMI). Reperfusion at the coronary microvascular level is important for STEMI and culprit plaque is associated with distal embolization and microvascular reperfusion. ST-segment resolution (ST-R) in the electrocardiogram reflects microvascular reperfusion after primary PCI. Longitudinal extent of lipid pool assessed by optical coherence tomography (OCT) may predict the risk of failure of microvascular reperfusion after primary PCI. METHODS AND RESULTS: This study consisted of 39 patients with STEMI who underwent primary PCI within 24h after the onset of chest pain. Immediately after thrombectomy, OCT was performed and length of lipid pool was measured. Microvascular reperfusion after primary PCI was assessed by ST-R, which was defined as >50% decrease in ST elevation at 1h after primary PCI. There were 23 patients with ST-R and 16 patients without ST-R, with no significant difference in baseline clinical and angiographical variables between the 2 groups. Final thrombolysis in myocardial infarction 3 flow was obtained in all of the patients. Peak creatine kinase was significantly higher in the ST-R (-) group than in the ST-R (+) group (p=0.01). Length of lipid pool was 10.1 ± 2.8mm in the ST-R (-) group and 7.8 ± 3.2mm in the ST-R (+) group (p=0.02). In receiver operating characteristics curve assessing the ability of length of lipid pool to predict ST-R, area under the curve was 0.74 (p=0.02). Length of lipid pool >9.0mm best predicted the absence of ST-R with sensitivity 88% and specificity 78%. CONCLUSIONS: These findings suggest that length of lipid pool estimated by OCT may predict microvascular no-reflow after primary PCI.

Three-dimensional T2-weighted imaging using the dark blood method for detecting pulmonary embolisms: comparison with computed tomography angiography.

PURPOSE: The aim of this study was to assess the potential diagnostic value of three-dimensional T2-weighted imaging using the dark blood method for detecting pulmonary embolism (PE). MATERIALS AND METHODS: Ten consecutive patients with already diagnosed acute PE (five men, five women; mean age 58.6 years, range 35-79 years) were prospectively enrolled in this study. All patients underwent lung magnetic resonance imaging (MRI) with a 1.5-T scanner. MRI was performed on the same day as CT angiography (CTA), which was undertaken to monitor treatment. Two radiologists performed a consensus evaluation of MRI followed by CTA on a per-vessel basis: the main pulmonary artery (PA), lobar PA, segmental PA, and subsegmental PA. Each modality was evaluated independently on separate days (at least 8 weeks apart). The accuracy of MRI for detecting PE was determined by comparing it with CTA results, which were used as a reference standard. Cohen's kappa analysis was used for statistical analyses. RESULTS: Among the 10 patients, pulmonary emboli were seen in 6 of 20 main arteries, 22 of 60 lobar arteries, 35 of 180 segmental arteries, and 8 of 410 subsegmental arteries on CTA. The sensitivities/specificities of MRI were 100%/100% for the main PA, 90.9%/97.3% for the lobar PA, and 74.2%/97.9% for the segmental PA, respectively. Altogether, 304 (83%) of 410 subsegmental arteries were not visualized on MRI and only 1 of the 8 emboli in the subsegmental branches was depicted. The kappa values for the main, lobar, and segmental arteries were 1.0, 0.89, and 0.77, respectively. CONCLUSION: Three-dimensional T2-weighted imaging using the dark blood method appears to be principally useful for diagnosing main, lobar, and segmental PEs.